Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 9Head & Neck 2Gynecologic 2Breast 2Thoracic 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 15Head and Neck Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Melanoma 6Urinary Bladder Neoplasms 5Carcinoma, Renal Cell 5Stomach Neoplasms 4Ovarian Neoplasms 4Carcinoma, Transitional Cell 4Carcinoma, Merkel Cell 4Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Neoplasms 3Colorectal Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Turcot syndrome 1Sarcoma 1Prostatic Neoplasms 1Nasopharyngeal Neoplasms 1Microsatellite Instability 1Mesothelioma, Malignant 1Gastrointestinal Neoplasms 1Epstein-Barr Virus Infections 1Diabetes Mellitus, Insulin-Dependent, 10 1Adrenocortical Carcinoma 1

Interventions

pembrolizumab 23Nivolumab 10Trastuzumab 7Gemcitabine 6Cisplatin 6Cetuximab 6Docetaxel 5spartalizumab 4atezolizumab 4Ipilimumab 4Drug Therapy 4Cyclophosphamide 4Carboplatin 4Capecitabine 4palbociclib 3fludarabine 3cemiplimab 3Radiotherapy 3Magnetic Resonance Spectroscopy 3Erlotinib Hydrochloride 3Bortezomib 3ulixertinib 2trametinib 2sargramostim 2pertuzumab 2avelumab 2amminedichloro(2-methylpyridine)platinum(II) 2aldesleukin 2Taxes 2TH 302 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × avelumab × Head & Neck × Clear all
NCT04954599 2025-10-07

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Maastricht University Medical Center

Phase 1/2 Recruiting
126 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT05395052 2023-09-21

FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Fate Therapeutics

Phase 1 Terminated
5 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡